WHO: Updates on Method Transfer

Recommendation
13-15 May 2025
Vienna, Austria
Practical Approaches for USP General Chapter <1058> Compliance in the QC Laboratory
In 2022, the WHO published the "Technical Report Series 1044, 2022" called "TRS 1044 - Annex 4: WHO guidelines on technology transfer in pharmaceutical manufacturing" on the subject of technology transfer. The previous document dates back to 2011 and has now been updated.
The new annex consists of the following chapters and subsections and also lists an appendix 1:
Background
Abbreviations
1. Introduction
2. Scope
3. Glossary
4. Due diligence and gap analysis
5. Organization and management
6. Quality management and quality risk management
7. Documentation
8. Premises
9. Equipment and instruments
10. Qualification and validation
11. Life cycle approach
12. Phases of a technology transfer project
Phase I: Project initiation
Phase II: Project planning
Phase III: Project transfer execution
Production (example: finished pharmaceutical product)
Quality control: analytical procedure transfer
Cleaning
Phase IV: Project review and close-out
References
Appendix 1 Documentation commonly required for technology transfer
Chapter 12 "Phases of a technology transfer project" under "Quality control: analytical procedure transfer" and Appendix 1 deal specifically with the topic of method transfer.
Annex 4 "TRS 1044 - Annex 4: WHO guidelines on technology transfer in pharmaceutical manufacturing" is available on the WHO website.
Related GMP News
12.03.2025EMA publishes Considerations regarding the Implementation of ICH M13A on Bioequivalence
12.03.2025Proposed Update to USP <1058> on Analytical Instrument and System Qualification
06.03.2025Eurachem publishes Leaflet on Analytical Equipment and Systems
06.03.2025Further Modifications to USP Chapter <621> Chromatography Published for Comment
26.02.2025FDA Warning Letter Highlights Responsibilities of Contract Testing Laboratories